Stamford Pharmaceuticals Overview
- Year Founded
-
1995
- Status
-
Private
- Employees
-
3
- Latest Deal Type
-
Series A
- Latest Deal Amount
-
$29.8M
- Investors
-
2
Stamford Pharmaceuticals General Information
Description
Operator of a cancer immunotherapy company intended to develop medicines to treat primary, recurrent and metastatic cancers. The company uses several different technologies and approaches utilizing viral vectors and affinity agents that can be conjugated to deliver biologicals, enabling doctors to utilize new and advanced treatments to cure patients even in advanced stages of cancer.
Contact Information
Website
www.stamfordpharmaceuticals.comCorporate Office
- 500 West 2nd Street
- Suite 1900
- Austin, TX 78701
- United States
Corporate Office
- 500 West 2nd Street
- Suite 1900
- Austin, TX 78701
- United States
Stamford Pharmaceuticals Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 5. Later Stage VC (Series A) | 28-Sep-2023 | $29.8M | Completed | Clinical Trials - Phase 3 | ||
| 4. Secondary Transaction - Private | 01-May-2021 | Completed | Pre-Clinical Trials | |||
| 3. IPO | 14-Nov-2014 | Cancelled | Pre-Clinical Trials | |||
| 2. Seed Round | 30-Nov-2012 | $3.17M | $3.17M | Completed | Pre-Clinical Trials | |
| 1. Seed Round | 01-Nov-2006 | Completed | Pre-Clinical Trials |
Stamford Pharmaceuticals Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series A-2 | ||||||||
| Series A-1 | ||||||||
| Seed 5 | ||||||||
| Seed 4 | ||||||||
| Seed 3 | ||||||||
| Seed 2 | 19,340,867 | $0.000100 | $0.11 | $0.11 | 1x | $0.11 | 7.26% | |
| Seed 1 | 22,013,144 | $0.000100 | $0.09 | $0.09 | 1x | $0.09 | 8.26% |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Opportunity Score
Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.
Exit Type
Evaluates the likelihood of a successful exit for investors, and the most likely exit type.
Stamford Pharmaceuticals Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Stamford Pharmaceuticals Patents
Stamford Pharmaceuticals Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2026147825-A1 | Patient stratification | Pending | 02-Jan-2025 | ||
| WO-2026076074-A1 | Functionalized viruses and related compositions and methods | Pending | 02-Oct-2024 |
Stamford Pharmaceuticals Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Stamford Pharmaceuticals Investors (2)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Prevail Partners | Venture Capital | Minority | ||
| Tenmile | Venture Capital | Minority |
Stamford Pharmaceuticals Acquisitions (1)
Stamford Pharmaceuticals’s most recent deal was a Merger/Acquisition with 4G Vaccines. The deal was made on 01-Jan-2012.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| 4G Vaccines | 01-Jan-2012 | Merger/Acquisition | Drug Discovery |
Stamford Pharmaceuticals FAQs
-
When was Stamford Pharmaceuticals founded?
Stamford Pharmaceuticals was founded in 1995.
-
Where is Stamford Pharmaceuticals headquartered?
Stamford Pharmaceuticals is headquartered in Austin, TX.
-
What is the size of Stamford Pharmaceuticals?
Stamford Pharmaceuticals has 3 total employees.
-
What industry is Stamford Pharmaceuticals in?
Stamford Pharmaceuticals’s primary industry is Drug Discovery.
-
Is Stamford Pharmaceuticals a private or public company?
Stamford Pharmaceuticals is a Private company.
-
What is the current valuation of Stamford Pharmaceuticals?
The current valuation of Stamford Pharmaceuticals is .
-
What is Stamford Pharmaceuticals’s current revenue?
The current revenue for Stamford Pharmaceuticals is .
-
How much funding has Stamford Pharmaceuticals raised over time?
Stamford Pharmaceuticals has raised $33M.
-
Who are Stamford Pharmaceuticals’s investors?
Prevail Partners and Tenmile have invested in Stamford Pharmaceuticals.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
